Related Experiment Video
Updated: Oct 17, 2025
03:37
Author Spotlight: Enhancing Cerebral Ischemia Research with a Simplified Rat Model
Published on: July 5, 2024
761
Combined Anticoagulation and Antiaggregation in Acute Cervical Artery Dissection
Philipp von Gottberg1, Victoria Hellstern1, Christina Wendl2
1Neuroradiologische Klinik, Klinikum Stuttgart, 70174 Stuttgart, Germany.
Journal of Clinical Medicine
|October 13, 2021
Summary
Combining anticoagulation (AC) plus antiplatelet therapy (AT) for cervical artery dissection (CAD) shows faster recanalization than AC or AT alone. This combination therapy appears safe, with similar adverse event rates to single therapies.
Area of Science:
- Neurology
- Vascular Medicine
Background:
- Cervical artery dissection (CAD) is a leading cause of stroke in young adults.
- Previous research indicates no significant difference between anticoagulation (AC) and antiplatelet therapy (AT) for CAD treatment.
- The efficacy and safety of combined AC and AT for acute CAD remain underexplored.
Purpose of the Study:
- To retrospectively evaluate the safety and efficacy of combined AC plus AT in patients with acute CAD.
- To compare outcomes of combined therapy with AC or AT monotherapy.
Main Methods:
- Retrospective analysis of 28 patients with acute CAD receiving AC plus single or dual AT.
- Angiographic follow-up assessed occlusion, stenosis, and recanalization.
- Comparison with 22 patients treated with AC or AT alone.
Main Results:
- Combined AC plus AT demonstrated more frequent and faster recanalization compared to AC/AT monotherapy.
- Adverse event frequency and severity were comparable across treatment groups.
- No major adverse events or deaths were reported in the combined therapy group.
Conclusions:
- Combining AC plus AT in acute CAD may offer improved and accelerated recanalization.
- This combination therapy appears to have a similar safety profile to monotherapy.
- Further prospective studies are warranted to confirm these findings.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.5K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
01:29Venous Thrombosis III: Interprofessional Care
60
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
60
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
753
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
753
01:22Aneurysm IV: Nursing Management
42
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
42
01:16Clot Retraction and Fibrinolysis
7.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.5K